HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nathan Scott Selected Research
Nathan Scott Research Topics
Disease
3
Neoplasms (Cancer)
03/2024 - 03/2012
1
B-Cell Lymphoma (Lymphoma, B Cell)
03/2024
1
Cytomegalovirus Retinitis
03/2024
1
Opportunistic Infections (Opportunistic Infection)
03/2024
1
Retinitis
03/2024
1
Retinal Detachment (Retinal Detachments)
07/2023
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1
Deglutition Disorders (Dysphagia)
01/2020
1
Blindness (Hysterical Blindness)
06/2017
1
Burns
06/2017
1
Inflammation (Inflammations)
06/2017
1
Dyslipidemias (Dyslipidemia)
05/2014
1
Neoplasm Metastasis (Metastasis)
03/2012
1
Lung Neoplasms (Lung Cancer)
03/2012
Drug/Important Bio-Agent (IBA)
1
Valganciclovir
FDA Link
03/2024
1
Chimeric Antigen Receptors
IBA
03/2024
1
Silicone Oils
IBA
07/2023
1
Gefitinib (Iressa)
FDA Link
01/2022
1
Solutions
IBA
01/2020
1
Oxygen (Dioxygen)
IBA
06/2017
1
Cytokines
IBA
06/2017
1
Alkalies
IBA
06/2017
1
Retinaldehyde (Retinal)
IBA
06/2017
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
06/2017
1
Monoclonal Antibodies
IBA
06/2017
1
Thyroid Hormone Receptors (Thyroid Hormone Receptor)
IBA
05/2014
1
Triazines
IBA
05/2014
1
Immunoconjugates (Immunoconjugate)
IBA
01/2013
1
Osteopontin
IBA
03/2012
1
Carboplatin (JM8)
FDA Link
Generic
03/2012
Therapy/Procedure
2
Therapeutics
03/2024 - 06/2017